Relapsed Diffuse Large B-Cell Lymphoma
Oncology
2
Pipeline Programs
1
Companies
1
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
U
ZYNLONTAApproved
loncastuximab tesirine
Unknown Companyinjection2021
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
ADC TherapeuticsLoncastuximab Tesirine
Clinical Trials (1)
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Start: Sep 2020Est. completion: Jun 2028
Phase 3Active Not Recruiting
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
5h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
7h ago
Executive Medical Director, Oncology Early Development
AbbVie
Florham Park, NJ
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
South San Francisco, CA
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
North Chicago, IL
8h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space